{"id":"W2605606572","doi":"10.1200/jco.2014.32.15_suppl.e19542","title":"Safety and use of bendamustine from the Bendamustine Expanded Access Trial in Canada (Bend-ACT).","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; CancerCare Manitoba; University of Calgary; Hôpital de l'Enfant-Jésus; Dalhousie University; BC Cancer Agency; University of Manitoba; Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Bendamustine; Rituximab; Internal medicine; Regimen; Adverse effect; Chronic lymphocytic leukemia; Refractory (planetary science); Surgery; Leukemia; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001672268,0.0004089165,0.0004926224,0.0002237216,0.0006504262,0.0007126086,0.0005203905,0.0006199997,0.00495317],"category_scores_gemma":[0.001405675,0.0002403423,0.0004075965,0.0005277766,0.0004496749,0.0002728225,0.0003935392,0.001167054,0.0004459046],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008187256,"about_ca_system_score_gemma":0.01358315,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3434877,"about_ca_topic_score_gemma":0.685475,"domain_scores_codex":[0.9993544,0.0002458438,0.00002277017,0.00005117567,0.0001719392,0.0001538492],"domain_scores_gemma":[0.9990913,0.00007828012,0.0001220947,0.00003174277,0.000198602,0.0004779871],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.616877,0.005822576,0.05416322,0.001499834,0.00108571,0.0004129477,0.0003941427,0.003635203,0.00782949,0.001813803,0.05202513,0.2544409],"study_design_scores_gemma":[0.4900087,0.0716752,0.3107221,0.0009347278,0.001770474,0.0007656118,0.0003109536,0.003434308,0.003369076,0.001008685,0.1159023,0.00009790759],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9248605,0.01657581,0.0007890944,0.003869935,0.000279616,0.004375221,0.01382707,0.00007808661,0.03534458],"genre_scores_gemma":[0.9730971,0.004102341,0.0011667,0.002212779,0.0001367943,0.001274791,0.009576994,0.00001933495,0.00841312],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3434877,"threshold_uncertainty_score":0.6829767,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2103166923879981,"score_gpt":0.4822272090694262,"score_spread":0.2719105166814281,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}